United Health Products Provides Update on FDA PMA Application
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provides an update on the company's FDA Premarket Approval application.
内华达州梅斯奎特，2022年11月28日(环球通讯社)--通过NewMediaWire--联合保健品公司(OTCPK：UEEC)，(UHP)今天提供该公司FDA上市前批准申请的最新情况。
UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation of manufacturing and packaging related Standard Operating Procedures (SOPs) and is now awaiting external laboratory test results on HemoStyp samples produced under its new manufacturing arrangement. Upon receipt and review of the sample analysis, the company expects to submit its full PMA application within a few days. There can be no assurance that the company's PMA application will be approved.
UHP继续向食品和药物管理局推进其上市前批准申请。正如10月31日的新闻稿所述，该公司已经完成了对制造和包装相关标准操作程序(SOP)的审查和文件编制，目前正在等待根据新的制造安排生产的HemoStyp样本的外部实验室测试结果。在收到并审查样本分析后，该公司预计将在几天内提交完整的PMA申请。不能保证该公司的PMA申请会获得批准。
About United Health Products -- UHP develops, manufactures and markets HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent. HemoStyp is an all-natural product designed to control bleeding. UHP currently offers a suite of hemostatic products to the dental, veterinary and emergency medicine markets, and is focused on gaining approval to access the human surgical market.
关于美联航保健品--超高压开发、制造和销售HemoStyp™，这是一种获得专利的中和氧化再生纤维素止血剂。HemoStyp是一种全天然产品，旨在控制出血。UHP目前向牙科、兽医和急救药物市场提供一系列止血产品，并专注于获得进入人类外科市场的批准。
For more information on UHP visit the company's new website: or contact the company at info@uhpcorp.com.
欲了解有关UHP的更多信息，请访问该公司的新网站：或通过INFO@uhpcorp.com联系该公司。
The company can also be reached by phone or text message at 475.755.1005.
也可以通过电话或短信475.755.1005联系到该公司。
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
根据1995年《私人证券诉讼改革法》所作的安全港声明：本新闻稿可能包含符合1933年《证券法》第27A条(经修订)和《1934年证券交易法》(经修订)第21E条的含义的前瞻性信息，包括含有“相信”、“预期”、“预期”或类似表述的陈述。这些前瞻性陈述涉及已知和未知的风险、不确定因素和其他因素，这些风险、不确定因素和其他因素可能导致公司的实际结果、业绩或成就与这些前瞻性陈述中明示或暗示的大不相同。